<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01051271</url>
  </required_header>
  <id_info>
    <org_study_id>PAU-200/1563</org_study_id>
    <nct_id>NCT01051271</nct_id>
  </id_info>
  <brief_title>Prophylaxis Against Metoclopramide-Induced Akathisia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pamukkale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pamukkale University</source>
  <brief_summary>
    <textblock>
      ABSTRACT&#xD;
&#xD;
      Study Objective:&#xD;
&#xD;
      To compare the effects of midazolam and diphenhydramine for the prevention of metoclopramide&#xD;
      induced akathisia.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      This randomized, double-blind and controlled trial aimed to investigate co-administered&#xD;
      midazolam versus diphenhydramine in the prophylaxis of metoclopramide induced akathisia.&#xD;
      Patients 18 through 65 years of age who presented to the ED with primary or secondary&#xD;
      complaints of nausea and/or moderate to severe vascular type headache were eligible for this&#xD;
      study. Patients were randomized to one of the fallowing three groups: (1) metoclopramide 10&#xD;
      mg + midazolam 1.5 mg (2) metoclopramide 10 mg + diphenhydramine 20 mg (3) metoclopramide 10&#xD;
      mg + placebo. Metoclopramide was administered as a 2 minutes bolus infusion. Midazolam,&#xD;
      diphenhydramine and normal saline solution administered as a 15 minutes slow infusion. Whole&#xD;
      procedure was observed, akathisia and sedation scores and vital changes were recorded.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>akathisia and sedation scores</measure>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">225</enrollment>
  <condition>Akathisia</condition>
  <arm_group>
    <arm_group_label>diphenhydramine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>midazolam</intervention_name>
    <description>midazolam 1.5 mg</description>
    <arm_group_label>diphenhydramine</arm_group_label>
    <arm_group_label>saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 through 65 years of age and 50-90 kg of weight who presented to the ED&#xD;
             with primary or secondary complaints of nausea and/or moderate to severe vascular type&#xD;
             headache were eligible for this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who had liver and renal insufficiency&#xD;
&#xD;
          -  Electrolyte imbalance&#xD;
&#xD;
          -  Acute respiratory symptoms&#xD;
&#xD;
          -  Chronic obstructive pulmonary disease&#xD;
&#xD;
          -  Blood pressure less than 90/60 mmHg&#xD;
&#xD;
          -  Uncooperative individuals&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  Pre-existing motor disorder&#xD;
&#xD;
          -  Restless legs syndrome-parkinson's disease&#xD;
&#xD;
          -  Organic brain disorder, (dementia etc.), epilepsy&#xD;
&#xD;
          -  Admitted to the ED due to acute psychiatric symptoms&#xD;
&#xD;
          -  Deprived mental status&#xD;
&#xD;
          -  Advanced hearing loss&#xD;
&#xD;
          -  Malnutrition&#xD;
&#xD;
          -  Acute asthma attack&#xD;
&#xD;
          -  Serious physical illness, especially glaucoma, prostatic hypertrophy, or cardiac&#xD;
             disease&#xD;
&#xD;
          -  Had a contraindication to anticholinergic medications&#xD;
&#xD;
          -  Within 3 days of study entry patients who had taken an antiemetic antihistaminic,&#xD;
             antipsychotic, antispasmodic, alpha-blocker, or Ca++2-channel blocker, or within 2&#xD;
             weeks of study entry patients who had taken an antidepressant, barbiturate,&#xD;
             benzodiazepine, other sedative/hypnotic, opioid, lithium, or illicit sympathomimetic&#xD;
             agent were excluded&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>January 15, 2010</study_first_submitted>
  <study_first_submitted_qc>January 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2010</study_first_posted>
  <last_update_submitted>January 15, 2010</last_update_submitted>
  <last_update_submitted_qc>January 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2010</last_update_posted>
  <keyword>metoclopramide</keyword>
  <keyword>akathisia</keyword>
  <keyword>midazolam</keyword>
  <keyword>diphenhydramine</keyword>
  <keyword>metoclopramide induced akathisia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

